These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2901252)

  • 1. The effect of neuroleptics and tardive dyskinesia on smooth-pursuit eye movement in chronic schizophrenics.
    Spohn HE; Coyne L; Spray J
    Arch Gen Psychiatry; 1988 Sep; 45(9):833-40. PubMed ID: 2901252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between smooth pursuit eye movements and tardive dyskinesia in schizophrenia.
    Ross DE; Buchanan RW; Lahti AC; Medoff D; Bartko JJ; Compton AD; Thaker GK
    Schizophr Res; 1998 May; 31(2-3):141-50. PubMed ID: 9689718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of tardive dyskinesia with increased frequency of eye movement disturbances in chronic schizophrenic patients. A clinical note.
    Oepen G; Thoden U; Warmke C
    Eur Arch Psychiatry Neurol Sci; 1990; 239(4):241-5. PubMed ID: 1969345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saccadic distractibility in schizophrenic patients with tardive dyskinesia.
    Thaker GK; Nguyen JA; Tamminga CA
    Arch Gen Psychiatry; 1989 Aug; 46(8):755-6. PubMed ID: 2568826
    [No Abstract]   [Full Text] [Related]  

  • 5. Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics.
    Spohn HE; Coyne L; Lacoursiere R; Mazur D; Hayes K
    Arch Gen Psychiatry; 1985 Sep; 42(9):849-59. PubMed ID: 2864028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smooth pursuit eye movements in schizophrenia: effects of neuroleptic treatment and caffeine.
    Litman RE; Hommer DW; Clem T; Rapaport MH; Pato CN; Pickar D
    Psychopharmacol Bull; 1989; 25(3):473-8. PubMed ID: 2576322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Never treated schizophrenic patients have no abnormal movements such as tardive dyskinesia].
    Chorfi M; Moussaoui D
    Encephale; 1985; 11(6):263-5. PubMed ID: 2869939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased saccadic distractibility in tardive dyskinesia: functional evidence for subcortical GABA dysfunction.
    Thaker GK; Nguyen JA; Tamminga CA
    Biol Psychiatry; 1989 Jan; 25(1):49-59. PubMed ID: 2563231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA agonist-induced changes in motor, oculomotor, and attention measures correlate in schizophrenics with tardive dyskinesia.
    Cassady SL; Thaker GK; Moran M; Birt A; Tamminga CA
    Biol Psychiatry; 1992 Aug; 32(4):302-11. PubMed ID: 1358231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of procyclidine on eye movements in schizophrenia.
    Ettinger U; Kumari V; Zachariah E; Galea A; Crawford TJ; Corr PJ; Taylor D; Das M; Sharma T
    Neuropsychopharmacology; 2003 Dec; 28(12):2199-208. PubMed ID: 12942142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia in schizophrenics under 60 years of age.
    Kolakowska T; Williams AO; Ardern M; Reveley MA
    Biol Psychiatry; 1986 Feb; 21(2):161-9. PubMed ID: 2868762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voluntary movement dysfunction in Huntington's disease and tardive dyskinesia.
    David AS; Jeste DV; Folstein MF; Folstein SE
    Acta Neurol Scand; 1987 Feb; 75(2):130-9. PubMed ID: 2883804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analyses of voluntary orofacial motor control in schizophrenia and tardive dyskinesia.
    Caligiuri MP; Harris MJ; Jeste DV
    Biol Psychiatry; 1988 Nov; 24(7):787-800. PubMed ID: 2906545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smooth pursuit eye movements in the evaluation of famotidine adjunctive therapy of schizophrenia: a preliminary report.
    Rosenberg PB; Rosse RB; Johri SK; Kendrick K; Fay-McCarthy M; Collins JP; Tsui LC; Wyatt RJ; Deutsch SI
    Clin Neuropharmacol; 1996 Jun; 19(3):276-81. PubMed ID: 8726548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reversibility of "permanent" tardive dyskinesia.
    Klawans HL; Tanner CM; Barr A
    Clin Neuropharmacol; 1984; 7(2):153-9. PubMed ID: 6145520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nicotine on leading saccades during smooth pursuit eye movements in smokers and nonsmokers with schizophrenia.
    Avila MT; Sherr JD; Hong E; Myers CS; Thaker GK
    Neuropsychopharmacology; 2003 Dec; 28(12):2184-91. PubMed ID: 12968127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smooth pursuit eye movements in epileptics under antiepileptic medication.
    Matsue Y; Wagatsuma S; Ito K; Okuma T
    Tohoku J Exp Med; 1981 Aug; 134(4):341-9. PubMed ID: 7324035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia. A discontinuation study.
    Glazer WM; Moore DC; Schooler NR; Brenner LM; Morgenstern H
    Arch Gen Psychiatry; 1984 Jun; 41(6):623-7. PubMed ID: 6145399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.